echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > FDA grants fast-track qualification to efruxifermin for the treatment of non-alcoholic steatohepatitis

    FDA grants fast-track qualification to efruxifermin for the treatment of non-alcoholic steatohepatitis

    • Last Update: 2021-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Compilenewborn

    Recently, the U.


    FTD aims to accelerate the development and rapid review of drugs for serious diseases to address serious unmet medical needs in key areas


    Currently, Akero is conducting two parallel phase 2b clinical trials to evaluate the efficacy and safety of efruxifermin in the treatment of patients with NASH


    NASH is a serious and potentially life-threatening disease and is the leading cause of liver failure and liver transplantation worldwide


    efruxifermin is a differentiated Fc-FGF21 fusion protein, which is engineered to mimic the balanced biological activity characteristics of natural FGF21


    FTD qualification is an important step in advancing the efruxifermin project, and it has the potential to bring the drug to more patients affected by NASH


    The FDA granted efruxifermin FTD based on recent clinical milestones to demonstrate the potential of efruxifermin in addressing NASH and reversing multiple drivers of fibrosis


    Reference source: Akero Therapeutics Receives FDA Fast Track Designation for Efruxifermin (EFX) for the Treatment of NASH

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.